Ajdary Soheila, Riazi-Rad Farhad, Alimohammadian Mohammad-Hossein, Pakzad Saeed-Reza
Immunology department, Pasteur Institute of Iran, Tehran, Islamic Republic of Iran.
J Infect. 2009 Aug;59(2):139-43. doi: 10.1016/j.jinf.2009.05.010. Epub 2009 Jun 6.
BACKGROUND: Leishmania (L.) tropica is the causative agent of anthroponotic cutaneous leishmaniasis (ACL) in Iran. The disease often heals within a year; however, the non-healing forms of disease are also known. The immunologic responses to L. major infection have been studied in depth, however little is known about the immune status of L. tropica-infected patients. MATERIALS AND METHODS: This study was conducted to evaluate T-cell responses to Leishmania antigen in non-healing patients, patients with acute lesion, and healthy donors. Peripheral blood mononuclear cells (PBMC) were cultured with antigen and lymphoproliferative responses were determined. Cytokine profile including gamma interferon (IFN-gamma), interleukin (IL)-5, and IL-13 in supernatants of stimulated cells was also determined. RESULTS: The results showed PBMC from both groups of patients proliferated vigorously in response to Leishmania antigens. The levels of IFN-gamma and IL-13 were comparable between patients with acute lesions and non-healing patients. Non-healing patients had significantly higher median levels of IL-5 than patients with acute lesions. The cells from healthy individuals did not respond to Leishmania antigens. CONCLUSIONS: High levels of IFN-gamma, IL-5, and IL-13 in non-healing patients suggest a mixed Th1/Th2 response, whereas patients with acute lesion respond to infection by Th1-type response.
背景:热带利什曼原虫是伊朗人兽共患皮肤利什曼病(ACL)的病原体。该病通常在一年内自愈;然而,也存在不愈合的病例。对硕大利什曼原虫感染的免疫反应已进行了深入研究,但对热带利什曼原虫感染患者的免疫状态了解甚少。 材料与方法:本研究旨在评估不愈合患者、急性病变患者和健康供体对利什曼原虫抗原的T细胞反应。外周血单个核细胞(PBMC)与抗原一起培养,并测定淋巴细胞增殖反应。还测定了刺激细胞上清液中的细胞因子谱,包括γ干扰素(IFN-γ)、白细胞介素(IL)-5和IL-13。 结果:结果显示,两组患者的PBMC对利什曼原虫抗原均有强烈增殖反应。急性病变患者和不愈合患者的IFN-γ和IL-13水平相当。不愈合患者的IL-5中位数水平显著高于急性病变患者。健康个体的细胞对利什曼原虫抗原无反应。 结论:不愈合患者中高水平的IFN-γ、IL-5和IL-13提示存在混合的Th1/Th2反应,而急性病变患者对感染的反应为Th1型反应。
Acta Cient Venez. 1998
FEMS Immunol Med Microbiol. 2009-12
J Epidemiol Glob Health. 2024-3
Iran J Public Health. 2023-8
Med Microbiol Immunol. 2021-6
Iran J Basic Med Sci. 2014-3